Advance Parkinson’s research with QMENTA's Imaging Hub: cutting-edge imaging, biomarker insights, and cloud-based tools for early detection and collaboration.
Parkinson's Disease (PD) is a complex and progressive neurodegenerative disorder that affects millions of people worldwide. Early detection, accurate diagnosis, and monitoring disease progression are critical to advancing research and improving patient outcomes. At QMENTA, we are dedicated to empowering researchers with the tools they need to revolutionize Parkinson’s research through advanced neuroimaging techniques. Our cloud-based platform provides seamless access to powerful technologies that can transform the way PD is studied, diagnosed, and treated.
QMENTA’s Imaging Hub integrates state-of-the-art MRI and PET imaging techniques, enabling researchers to explore key biomarkers such as iron accumulation in the substantia nigra, Dopamine metabolism, and white matter microstructural changes—all essential for early detection and differentiation of PD from other parkinsonian syndromes like Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP). Advanced MRI acquisitions, such as Quantitative Susceptibility Mapping (QSM), Diffusion Tensor Imaging (DTI), and functional MRI (fMRI) provide detailed insights into both the structural and functional changes in the brain, helping researchers identify disease-related changes even before clinical symptoms manifest.
Our platform’s easy-to-use interface allows researchers to process, analyze, and collaborate on vast amounts of neuroimaging data, streamlining workflows and ensuring consistent results. With QMENTA, you can leverage cutting-edge MRI and molecular imaging modalities to study cognitive deficits, motor symptoms, and functional connectivity in PD patients. Moreover, the platform’s collaborative features enable institutions and research teams across the globe to work together effortlessly, accelerating the pace of discovery.
To dive deeper into the potential of neuroimaging in Parkinson's research, explore our latest comprehensive review, which provides a detailed overview of the state-of-the-art techniques driving innovation in this field. Let QMENTA be your partner in advancing Parkinson's research and shaping the future of neurodegenerative disease understanding.
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses
Discover Hybrid Cloud Imaging on QMENTA: merging automated & manual processes for peak accuracy in medical imaging.